Treace Medical Concepts
TMCI
116 hedge funds and large institutions have $127M invested in Treace Medical Concepts in 2026 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 38 increasing their positions, 32 reducing their positions, and 30 closing their positions.
481% more call options, than puts
Call options by funds: $657K | Put options by funds: $113K
163% more capital invested
Capital invested by funds: $48.3M → $127M (+$78.5M)
19% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 32
0% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 30
2% less funds holding
Funds holding: 118 → 116 (-2)
6.61% less ownership
Funds ownership: 55.72% → 49.1% (-6.6%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GA
Gagnon Advisors
New York
|
+$4.22M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$2.92M |
| 3 |
Vanguard Capital Management
Malvern,
Pennsylvania
|
+$1.56M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$1.2M |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
+$712K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GS
Gagnon Securities
New York
|
-$5.97M |
| 2 |
BlackRock
New York
|
-$5.39M |
| 3 |
State Street
Boston,
Massachusetts
|
-$2.75M |
| 4 |
Renaissance Technologies
New York
|
-$1.3M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$1.2M |
TMCI Hedge Fund Activity: Q2 2026 in Review
116 of the 8,350 institutional investors tracked by Wall St. Rank reported a position in Treace Medical Concepts (TMCI) for Q2 2026, worth a combined $127M — up 163% from $48.3M a quarter earlier.
Fund positioning in TMCI was balanced in Q2 2026: 30 funds opened new positions, 30 closed out, 38 added to existing stakes and 32 trimmed.
The largest buyer was Gagnon Advisors, opening a new position worth an estimated $4.22M. The largest seller was Gagnon Securities, cutting an estimated $5.97M.
- 116 institutional investors held Treace Medical Concepts (TMCI) as of Q2 2026, down from 118 in Q1 2026.
- Funds reported $127M of Treace Medical Concepts stock for Q2 2026, up 163% quarter-over-quarter.
- 30 funds opened new Treace Medical Concepts positions in Q2 2026 and 30 closed out, a net change of 0 holders.
- The largest Treace Medical Concepts buyer in Q2 2026 was Gagnon Advisors, an estimated $4.22M added.
- The largest Treace Medical Concepts seller in Q2 2026 was Gagnon Securities, an estimated $5.97M sold.
Based on aggregated 13F filings for Q2 2026.